Sarah Libring

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Venues

Oncogene

Cancers

Cancer research communications

Biology of the cell

Rutgers University New Brunswick

Purdue University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rutgers University New Brunswick

United States

Learning Center Peer Tutor

Purdue University

United States

Summer Researcher (SURF REU) :: Biomedical Eng & Electrical Eng

University of Texas at Austin

United States

Summer Researcher (BME CUReS Cancer REU) :: Biomedical Engineering

Education History

Purdue University Jul 15 2017

United States

PHD :: Biomedical Engineering

Rutgers University New Brunswick Aug 01 2013 - May 15 2017

United States

BSC :: Biomedical Engineering

Publications

Madison E Bates, Sarah Libring, Cynthia A Reinhart-King
Forces exerted and transduced by Cancer-Associated fibroblasts during cancer progression. Biology of the cell (2023)
Kayla F Goliwas, Sarah Libring, Emily Berestesky, Shayan Gholizadeh, Samantha C Schwager, Andra R Frost, Thomas R Gaborski, Jian Zhang, Cynthia A Reinhart-King
Mitochondrial transfer from cancer associated fibroblasts increases migration in aggressive breast cancer. Journal of cell science (2023)
Ammara Abdullah, Saeed Salehin Akhand, Juan Sebastian Paez Paez, Wells Brown, Li Pan, Sarah Libring, Michael Badamy, Emily C Dykhuizen, Luis Solorio, Weiguo Andy Tao, Michael K Wendt
Correction: Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer. Oncogene (2023)
Hao Chen, Gregory M Cresswell, Sarah Libring, Mitchell G Ayers, Jinmin Miao, Zhong-Yin Zhang, Luis Solorio, Timothy L Ratliff, Michael K Wendt
Tumor Cell-Autonomous SHP2 Contributes to Immune Suppression in Metastatic Breast Cancer. Cancer research communications 2 (10) (2022)
Hao Chen, Gregory M Cresswell, Sarah Libring, Mitchell G Ayers, Jinmin Miao, Zhong-Yin Zhang, Luis Solorio, Timothy L Ratliff, Michael K Wendt
Tumor Cell-Autonomous SHP2 Contributes to Immune Suppression in Metastatic Breast Cancer. Cancer research communications 2 (10) (2022)
Sarah Libring, Ángel Enríquez, Hyowon Hugh Lee, Luis Solorio
In Vitro Magnetic Techniques for Investigating Cancer Progression. Cancers 13 (17) (2021)
Ammara Abdullah, Saeed Salehin Akhand, Juan Sebastian Paez Paez, Wells Brown, Li Pan, Sarah Libring, Michael Badamy, Emily C Dykhuizen, Luis Solorio, Weiguo Andy Tao, Michael K Wendt
Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer. Oncogene 40 (2) (2020)
Brian H Jun, Tianqi Guo, Sarah Libring, Monica K Chanda, Juan Sebastian Paez, Aparna Shinde, Michael K Wendt, Pavlos P Vlachos, Luis Solorio
Fibronectin-Expressing Mesenchymal Tumor Cells Promote Breast Cancer Metastasis. Cancers 12 (9) (2020)
Sarah Libring, Aparna Shinde, Monica K Chanda, Maryam Nuru, Heather George, Aya M Saleh, Ammara Abdullah, Tamara L Kinzer-Ursem, Sarah Calve, Michael K Wendt, Luis Solorio
The Dynamic Relationship of Breast Cancer Cells and Fibroblasts in Fibronectin Accumulation at Primary and Metastatic Tumor Sites. Cancers 12 (5) (2020)
Hao Chen, Sarah Libring, Kasi Viswanatharaju Ruddraraju, Jinmin Miao, Luis Solorio, Zhong-Yin Zhang, Michael K Wendt
SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer. Oncogene 39 (49) (2020)

Sarah Libring.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sarah Libring